Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Pretta

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Targeted Oncology|January 23, 2023
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma PatientsMargherita Rimini, Carles Fabregat-Franco, Mara Persano, et al.
Cancers|May 17, 2020
Molecular-Biology-Driven Treatment for Metastatic Colorectal CancerEleonora Lai, Nicole Liscia, Clelia Donisi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2023
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung ScorePina Ziranu, Paolo Albino Ferrari, Francesco Guerrera, et al.
The Oncologist|March 19, 2026
Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: comparative outcomes and AI-guided treatment selectionLetizia Procaccio, Guido Giordano, Federico Nichetti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2023
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world dataMargherita Rimini, Lorenzo Fornaro, Sara Lonardi, et al.
Targeted Oncology|May 1, 2024
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter StudyMargherita Rimini, Gianluca Masi, Sara Lonardi, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Targeted Oncology|January 23, 2023
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma PatientsMargherita Rimini, Carles Fabregat-Franco, Mara Persano, et al.
Cancers|May 17, 2020
Molecular-Biology-Driven Treatment for Metastatic Colorectal CancerEleonora Lai, Nicole Liscia, Clelia Donisi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2023
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung ScorePina Ziranu, Paolo Albino Ferrari, Francesco Guerrera, et al.
The Oncologist|March 19, 2026
Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: comparative outcomes and AI-guided treatment selectionLetizia Procaccio, Guido Giordano, Federico Nichetti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2023
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world dataMargherita Rimini, Lorenzo Fornaro, Sara Lonardi, et al.
Targeted Oncology|May 1, 2024
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter StudyMargherita Rimini, Gianluca Masi, Sara Lonardi, et al.
Pageof 6